<SEC-DOCUMENT>0000785161-20-000009.txt : 20200221
<SEC-HEADER>0000785161-20-000009.hdr.sgml : 20200221
<ACCEPTANCE-DATETIME>20200221163656
ACCESSION NUMBER:		0000785161-20-000009
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20200219
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200221
DATE AS OF CHANGE:		20200221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Encompass Health Corp
		CENTRAL INDEX KEY:			0000785161
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				630860407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10315
		FILM NUMBER:		20640596

	BUSINESS ADDRESS:	
		STREET 1:		9001 LIBERTY PARKWAY
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35242
		BUSINESS PHONE:		205-967-7116

	MAIL ADDRESS:	
		STREET 1:		9001 LIBERTY PARKWAY
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35242

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHSOUTH CORP
		DATE OF NAME CHANGE:	19950113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHSOUTH REHABILITATION CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>february2020executivec.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:27DD7901BEC357C89F71881AC890B137,x:9bf9d186eb304bf189a6c428eb16e7b0-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2019-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2019-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2019-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2019-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2019-01-31" xmlns:lea="http://fasb.org/dis/lea/2019-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2019-01-31" xmlns:guar="http://fasb.org/dis/guar/2019-01-31" xmlns:ru="http://fasb.org/dis/ru/2019-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2019-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2019-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2019-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2019-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:cce="http://fasb.org/dis/cce/2019-01-31" xmlns:inv="http://fasb.org/dis/inv/2019-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:srt-std="http://fasb.org/srt-std/2019-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2019-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2019-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2019-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2019-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2019-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2019-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2019-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:re="http://fasb.org/dis/re/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2019-01-31" xmlns:invco="http://fasb.org/dis/invco/2019-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2019-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2019-01-31" xmlns:currency-ent-dep="http://xbrl.sec.gov/currency-ent-dep/2019-01-31" xmlns:aro="http://fasb.org/dis/aro/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:srt-all="http://fasb.org/srt-all/2019-01-31" xmlns:codification-part="http://fasb.org/codification-part/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:sec-re="http://fasb.org/dis/sec-re/2019-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2019-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2019-01-31" xmlns:equity="http://fasb.org/dis/equity/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:se="http://fasb.org/dis/se/2019-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2019-01-31" xmlns:edco="http://fasb.org/dis/edco/2019-01-31" xmlns:te="http://fasb.org/dis/te/2019-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2019-01-31" xmlns:invest-all="http://xbrl.sec.gov/invest-all/2013-01-31" xmlns:hco="http://fasb.org/dis/hco/2019-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:dr="http://fasb.org/dis/dr/2019-01-31" xmlns:ero="http://fasb.org/dis/ero/2019-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2019-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2019-01-31" xmlns:ehc="http://www.encompasshealth.com/20200219" xmlns:rpd="http://fasb.org/dis/rpd/2019-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2019-01-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2019-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2019-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2019-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2019-01-31" xmlns:soi="http://fasb.org/stm/soi/2019-01-31" xmlns:diha="http://fasb.org/dis/diha/2019-01-31" xmlns:debt="http://fasb.org/dis/debt/2019-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:invest-std="http://xbrl.sec.gov/invest-std/2013-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2019-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2019-01-31" xmlns:invest-ent-all="http://xbrl.sec.gov/invest-ent-all/2013-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2019-01-31" xmlns:rd="http://fasb.org/dis/rd/2019-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2019-01-31" xmlns:eui="http://fasb.org/dis/eui/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ap="http://fasb.org/dis/ap/2019-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2019-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2019-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2019-01-31" xmlns:sr="http://fasb.org/dis/sr/2019-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2019-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2019-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2019-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2019-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2019-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2019-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2019-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2019-01-31" xmlns:oi="http://fasb.org/dis/oi/2019-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2019-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2019-01-31" xmlns:cc="http://fasb.org/dis/cc/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2019-01-31" xmlns:disops="http://fasb.org/dis/disops/2019-01-31" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:cn-part="http://fasb.org/cn-part/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2019-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2019-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2019-01-31" xmlns:ts="http://fasb.org/dis/ts/2019-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2019-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2019-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:ni="http://fasb.org/dis/ni/2019-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2019-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2019-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2019-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2019-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2019-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2019-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2019-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:ir="http://fasb.org/dis/ir/2019-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2019-01-31" xmlns:foct="http://fasb.org/dis/foct/2019-01-31" xmlns:soc="http://fasb.org/stm/soc/2019-01-31" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2019-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2019-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2019-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:con="http://fasb.org/dis/con/2019-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:invest-ent-std="http://xbrl.sec.gov/invest-ent-std/2013-01-31" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2019-01-31" xmlns:eps="http://fasb.org/dis/eps/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2019-01-31" xmlns:pay="http://fasb.org/dis/pay/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:tin-part="http://fasb.org/tin-part/2019-01-31" xmlns:acec="http://fasb.org/dis/acec/2019-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2019-01-31" xmlns:nt="http://fasb.org/dis/nt/2019-01-31" xmlns:spc="http://fasb.org/stm/spc/2019-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2019-01-31" xmlns:ides="http://fasb.org/dis/ides/2019-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2019-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:regop="http://fasb.org/dis/regop/2019-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2019-01-31" xmlns:com="http://fasb.org/stm/com/2019-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2019-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2019-01-31" xmlns:exch-ent-dep="http://xbrl.sec.gov/exch-ent-dep/2019-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ei="http://fasb.org/dis/ei/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="D2020Q1Feb19-2020throughFeb19-2020" name="dei:AmendmentFlag" id="Fact-E978957CA507524688EE9CFFAB6C4617-wk-Fact-E978957CA507524688EE9CFFAB6C4617" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="D2020Q1Feb19-2020throughFeb19-2020" name="dei:EntityCentralIndexKey" id="Fact-8D26389E1F085441B09086D7D4D8C24A-wk-Fact-8D26389E1F085441B09086D7D4D8C24A">0000785161</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="ehc-20200219.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="D2020Q1Feb19-2020throughFeb19-2020">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000785161</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-02-19</xbrli:startDate>
			<xbrli:endDate>2020-02-19</xbrli:endDate>
		</xbrli:period>
	</xbrli:context></ix:resources></ix:header></div><div><a id="sE76A317BD7D05BD494CC6B3D6744851D"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-top:12px;text-align:center;"><hr></hr></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:120%;padding-bottom:13px;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">WASHINGTON, D.C. 20549</span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM </span><span><ix:nonNumeric id="d43646476e94-wk-Fact-B41F40D49B2354B1A603B0011EE7B261" name="dei:DocumentType" contextRef="D2020Q1Feb19-2020throughFeb19-2020"><span style="font-size:18pt;font-weight:bold;">8-K</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:18pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:13pt;"><span style="font-family:inherit;font-size:13pt;font-weight:bold;">CURRENT REPORT</span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="line-height:120%;padding-top:13px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Date of Report (date of earliest event reported): </span><span style="font-family:inherit;font-size:10pt;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d43646476e108-wk-Fact-6F2C87EC974A54128564087E9E6E3560" name="dei:DocumentPeriodEndDate" contextRef="D2020Q1Feb19-2020throughFeb19-2020" format="ixt:datemonthdayyearen">February 19, 2020</ix:nonNumeric></span></span></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:28pt;"><span><ix:nonNumeric id="d43646476e113-wk-Fact-19C8521BB0FE5799B79FF73CDDD070E7" name="dei:EntityRegistrantName" contextRef="D2020Q1Feb19-2020throughFeb19-2020"><span style="font-size:28pt;font-weight:bold;">Encompass Health Corporation</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:28pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Exact name of Registrant as specified in its Charter)</span></div><div style="line-height:120%;padding-top:24px;text-align:center;font-size:10pt;"><span><ix:nonNumeric id="d43646476e122-wk-Fact-0F022CDC6D2C52F4B012EABC06888552" name="dei:EntityIncorporationStateCountryCode" contextRef="D2020Q1Feb19-2020throughFeb19-2020" format="ixt-sec:stateprovnameen"><span style="font-weight:bold;text-decoration:underline;">Delaware</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span></div><div style="line-height:120%;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(State or Other Jurisdiction of Incorporation)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.40625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;"><span><ix:nonNumeric id="d43646476e144-wk-Fact-7106E2FD3B655B3782D962D5A6BBF533" name="dei:EntityFileNumber" contextRef="D2020Q1Feb19-2020throughFeb19-2020">001-10315</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;"><span><ix:nonNumeric id="d43646476e149-wk-Fact-6C326105A17359F6860CF30D36CB7276" name="dei:EntityTaxIdentificationNumber" contextRef="D2020Q1Feb19-2020throughFeb19-2020">63-0860407</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Commission File Number)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(IRS Employer Identification No.)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span><ix:nonNumeric id="d43646476e174-wk-Fact-F61F99B4129F5AA6B15D9A0E29CF591F" name="dei:EntityAddressAddressLine1" contextRef="D2020Q1Feb19-2020throughFeb19-2020"><span style="font-weight:bold;text-decoration:underline;">9001 Liberty Parkway</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">, </span><span><ix:nonNumeric id="d43646476e179-wk-Fact-A400BD59D9CB5157A97D470F29FE155C" name="dei:EntityAddressCityOrTown" contextRef="D2020Q1Feb19-2020throughFeb19-2020"><span style="font-weight:bold;text-decoration:underline;">Birmingham</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">, </span><span><ix:nonNumeric id="d43646476e184-wk-Fact-B97B1374D21952BD8AAD0BC53E08136C" name="dei:EntityAddressStateOrProvince" contextRef="D2020Q1Feb19-2020throughFeb19-2020" format="ixt-sec:stateprovnameen"><span style="font-weight:bold;text-decoration:underline;">Alabama</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span><span><ix:nonNumeric id="d43646476e189-wk-Fact-5EDDB24E37225A5689A518DD741A13F3" name="dei:EntityAddressPostalZipCode" contextRef="D2020Q1Feb19-2020throughFeb19-2020"><span style="font-weight:bold;text-decoration:underline;">35242</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span></div><div style="line-height:120%;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Address of Principal Executive Offices, Including Zip Code)</span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">(</span><span><ix:nonNumeric id="d43646476e200-wk-Fact-132998FB6FFA523AA8F04C3A75C27AF8" name="dei:CityAreaCode" contextRef="D2020Q1Feb19-2020throughFeb19-2020"><span style="font-weight:bold;text-decoration:underline;">205</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">)&#160;</span><span><ix:nonNumeric id="d43646476e205-wk-Fact-527D2FBC0BE35D8D816A994D7E4159F1" name="dei:LocalPhoneNumber" contextRef="D2020Q1Feb19-2020throughFeb19-2020"><span style="font-weight:bold;text-decoration:underline;">967-7116</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;"> </span></div><div style="line-height:120%;padding-top:2px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="line-height:120%;padding-bottom:13px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:7%;"></td><td style="width:93%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d43646476e229-wk-Fact-2AE0B89C9F0358E598A780DEFE4DC7A4" name="dei:WrittenCommunications" contextRef="D2020Q1Feb19-2020throughFeb19-2020" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d43646476e251-wk-Fact-3588505CE5B558598119DDA7728E1385" name="dei:SolicitingMaterial" contextRef="D2020Q1Feb19-2020throughFeb19-2020" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d43646476e273-wk-Fact-D1C4994AFF865DB08E8C86F9BC1ED1C3" name="dei:PreCommencementIssuerTenderOffer" contextRef="D2020Q1Feb19-2020throughFeb19-2020" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d43646476e295-wk-Fact-CD02BE6F69CA54E28794E30F7586A7BA" name="dei:PreCommencementTenderOffer" contextRef="D2020Q1Feb19-2020throughFeb19-2020" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. &#160;&#160;&#160;&#160;Emerging growth company&#160;&#160;      </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d43646476e307-wk-Fact-C5D2ADD2BDD1544FA9C4BF03A64B1316" name="dei:EntityEmergingGrowthCompany" contextRef="D2020Q1Feb19-2020throughFeb19-2020" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange   Act. &#9744;</span></div><div style="line-height:120%;padding-bottom:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="line-height:120%;padding-bottom:13px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.9453125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:38%;"></td><td style="width:18%;"></td><td style="width:44%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Title of each class</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Trading Symbol(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Name of each exchange on which registered</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d43646476e348-wk-Fact-D19C5C5E149A5E24887951296B58E8F4" name="dei:Security12bTitle" contextRef="D2020Q1Feb19-2020throughFeb19-2020">Common Stock, par value $0.01 per share</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d43646476e353-wk-Fact-07B9233F48C956ECBC3FFC26E859C806" name="dei:TradingSymbol" contextRef="D2020Q1Feb19-2020throughFeb19-2020">EHC</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d43646476e358-wk-Fact-8316355A38E152E09EB39B82DCD2B362" name="dei:SecurityExchangeName" contextRef="D2020Q1Feb19-2020throughFeb19-2020" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;"><hr></hr></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s456A1723354A50349F949215F46E9445"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 5.02.</span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Compensatory Arrangements of Certain Officers.</span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At regularly scheduled meetings on February 19-20, 2020, the Board of Directors of Encompass Health Corporation (&#8220;Encompass Health&#8221;) and its Compensation and Human Capital Committee (the &#8220;Committee&#8221;) undertook the customary review and approval of annual compensation decisions. The Committee oversees Encompass Health&#8217;s compensation and employee benefit objectives, plans and policies and reviews and approves the compensation of executive officers, except that of the Chief Executive Officer which is ultimately approved by the independent members of the Board. The following changes to the 2020 incentive compensation opportunities of certain named executive officers were approved:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Mr. Mark J. Tarr, President and Chief Executive Officer</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:72px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:601px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:274px;"></td><td style="width:162px;"></td><td style="width:162px;"></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Component</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Previous</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Newly Approved</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Target Annual Cash Incentive Opportunity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">115% of base salary</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">120% of base salary</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Target Long-Term Equity Incentive Opportunity</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$4,600,000</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$4,700,000</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:72px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Ms. Barbara A. Jacobsmeyer, Executive Vice President and President, Inpatient Hospitals</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:72px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:601px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:274px;"></td><td style="width:162px;"></td><td style="width:162px;"></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Component</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Previous</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Newly Approved</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Target Annual Cash Incentive Opportunity</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">80% of base salary</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">85% of base salary</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Target Long-Term Equity Incentive Opportunity</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">175% of base salary</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">225% of base salary</span></div></td></tr></table></div></div><div style="line-height:120%;text-indent:54px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Mr. Douglas E. Coltharp, Executive Vice President and Chief Financial Officer</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:72px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:601px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:274px;"></td><td style="width:162px;"></td><td style="width:162px;"></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Component</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Previous</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Newly Approved</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Target Long-Term Equity Incentive Opportunity</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">200% of base salary</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">250% of base salary</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:72px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">No other material changes to Encompass Health&#8217;s executive compensation plans and arrangements, which are otherwise described in the section captioned &#8220;Executive Compensation&#8221; in its Definitive Proxy Statement on Schedule 14A filed on March 21, 2019, were approved at these meetings.</span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s3735bf241c6b48c58c8955e03213bf9d"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;8.01.  </span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Events</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;">.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As previously disclosed, at the time that Encompass Health acquired its home health and hospice business through the purchase of EHHI Holdings, Inc. (&#8220;EHHI&#8221;) in December 2014, certain sellers of EHHI who were members of EHHI management (the &#8220;Management Investors&#8221;) contributed a portion of their shares of EHHI common stock, valued at approximately $64&#160;million on the acquisition date, to a subsidiary of Encompass Health (&#8220;Holdings&#8221;) that was formed in order to complete the acquisition and that is an indirect parent of EHHI, in exchange for approximately 16.7% of the outstanding shares of common stock of Holdings (the &#8220;Rollover Shares&#8221;). Pursuant to a stockholders agreement entered into among Encompass Health, Holdings and the Management Investors, the Management Investors had the right (but not the obligation) after December 31, 2017 to have their Rollover Shares purchased by Encompass Health for a cash purchase price per share equal to their fair value.  </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2018 and July 2019, the Management Investors exercised their right to sell Rollover Shares to Encompass Health, with Encompass Health having settled these exercises upon the payment in cash of approximately $65&#160;million and approximately $163&#160;million, respectively.  </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2020, Encompass Health received exercise notices for additional Rollover Shares, which Encompass Health settled for approximately $162&#160;million in cash in February 2020.&#160; Upon settlement of these exercises, approximately $46 million of the Rollover Shares remain outstanding, of which (i)&#160;approximately $45&#160;million are held by HCHB Consulting, Inc. (&#8220;HCHB&#8221;), an entity in which April Anthony, the chief executive officer of EHHI and an executive officer of Encompass Health, has a material interest, and (ii)&#160;approximately $1&#160;million are held by another Management Investor (together with HCHB, the &#8220;Subsidiary Shareholders&#8221; and, each, a &#8220;Subsidiary Shareholder&#8221;).</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On February 20, 2020, Encompass Health entered into an exchange agreement (each, an &#8220;Exchange Agreement&#8221;) with each of the Subsidiary Shareholders, pursuant to which they have the right to exchange all of the remaining Rollover Shares held by them for shares of common stock of Encompass Health (the &#8220;EHC Shares&#8221;).  Each of the Exchange Agreements provides that the Subsidiary Shareholder must deliver a written exchange notice (an &#8220;Exchange Notice&#8221;) to Encompass Health in order to exchange his or her remaining Rollover Shares for EHC Shares. Each Exchange Agreement further provides that the number of EHC Shares to be delivered to the Subsidiary Shareholder is to be determined by dividing the fair value of the Rollover Shares held by the Subsidiary Shareholder on the date of the Exchange Agreement by the last reported sales price of Encompass Health&#8217;s common stock on the New York Stock Exchange (the &#8220;NYSE&#8221;) on the date of delivery of the Exchange Notice. </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On February 20, 2020, Encompass Health received an Exchange Notice from each of the Subsidiary Shareholders.  Based on the last sales price of the Company&#8217;s common stock on the NYSE on February 20, 2020, the Company anticipates delivering an aggregate of approximately 561,000 EHC Shares to the Subsidiary Shareholders, with the settlement of the exchanges expected to occur prior to the end of the first quarter of 2020. The total number of EHC Shares to be issued to the Subsidiary Shareholders pursuant to the Exchange Agreements represents less than 0.6% of the total number of outstanding shares of the Company&#8217;s common stock. The Company anticipates issuing the EHC Shares from its treasury shares. The EHC Shares to be issued to the Subsidiary Shareholders are being issued in a transaction exempt from registration under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and will constitute &#8220;restricted securities&#8221; within the meaning of Rule 144 under the Securities Act. Following the settlement of the exchange transaction, Holdings and EHHI will be wholly-owned subsidiaries of Encompass Health.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The foregoing description of the terms of the Exchange Agreements is not intended to be complete and is qualified in its entirety by reference to the Exchange Agreement with HCHB, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Forward-Looking Statements</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#212529;">Statements contained in this Current Report on Form 8-K which are not historical facts, such as those relating to the anticipated settlement of the exchange of Rollover Shares for EHC Shares pursuant to the terms of the Exchange Agreements and the status of </span><span style="font-family:inherit;font-size:10pt;">Holdings and EHHI</span><span style="font-family:inherit;font-size:10pt;color:#212529;"> following the exchange, are forward-looking statements.  In addition, </span><span style="font-family:inherit;font-size:10pt;">Encompass Health</span><span style="font-family:inherit;font-size:10pt;color:#212529;">, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein.  All such estimates, projections and forward-looking information speak only as of the date hereof, and </span><span style="font-family:inherit;font-size:10pt;">Encompass Health</span><span style="font-family:inherit;font-size:10pt;color:#212529;"> undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise.  Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties.  Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such </span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;color:#212529;">factors, factors which could cause actual events or results to differ materially from those estimated by </span><span style="font-family:inherit;font-size:10pt;">Encompass Health</span><span style="font-family:inherit;font-size:10pt;color:#212529;"> include, but are not limited to, </span><span style="font-family:inherit;font-size:10pt;">Encompass Health</span><span style="font-family:inherit;font-size:10pt;color:#212529;">&#8217;s ability to consummate the exchange of Rollover Shares for EHC Shares on the terms described or at all; and other factors which may be identified from time to time in </span><span style="font-family:inherit;font-size:10pt;">Encompass Health</span><span style="font-family:inherit;font-size:10pt;color:#212529;">&#8217;s SEC filings and other public announcements, including its Form 10-K for the year ended December 31, 2018 and Forms 10-Q for the quarters ended March 31, 2019, June 30, 2019 and September 30, 2019. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><a id="sd4b914e75da14b348cfb207fb3cde192"></a></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01.  </span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Financial Statements and Exhibits</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;">.</span></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(d)&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:11%;"></td><td style="width:2%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Description</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex101exchangeagreement.htm"><span style="font-family:inherit;font-size:10pt;">10.1</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex101exchangeagreement.htm"><span style="font-family:inherit;font-size:10pt;">Exchange Agreement, dated February 20, 2020, by and among HCHB Consulting, Inc., Encompass Health Corporation, and Encompass Health Home Health Holdings, Inc.</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">104</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document</span></div></td></tr></table></div></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sF683900BC6AE5C988A0B4F98526E64FD"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:13px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;padding-left:192px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:13px;text-align:right;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:55.859375%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:12%;"></td><td style="width:80%;"></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">ENCOMPASS HEALTH CORPORATION</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">By:</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">/</span><span style="font-family:inherit;font-size:7pt;">S</span><span style="font-family:inherit;font-size:10pt;">/  P</span><span style="font-family:inherit;font-size:7pt;">ATRICK </span><span style="font-family:inherit;font-size:10pt;">D</span><span style="font-family:inherit;font-size:7pt;">ARBY</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Name:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Patrick Darby</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Title:</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Executive Vice President, General Counsel and Secretary</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dated: February 21, 2020</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101exchangeagreement.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s11C1DBF77A1ED1D3B8D2666B3CD9E2CF"></a></div><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 10.1</font></div><div style="line-height:120%;padding-bottom:16px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXCHANGE AGREEMENT</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Exchange Agreement (this &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;) is entered into as of February 20, 2020, by and between Encompass Health Corporation, a Delaware corporation (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Company</font><font style="font-family:inherit;font-size:12pt;">&#8221;), HCHB Consulting, Inc., a Delaware corporation (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Shareholder</font><font style="font-family:inherit;font-size:12pt;">&#8221;) and, solely for purposes of Section 1 hereof, Encompass Health Home Health Holdings, Inc., a Delaware corporation (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Subsidiary</font><font style="font-family:inherit;font-size:12pt;">&#8221;).</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">RECITALS</font></div><div style="line-height:120%;padding-left:0px;padding-bottom:16px;text-align:justify;text-indent:48px;"><font style="padding-bottom:16px;text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">A.</font><font style="font-family:inherit;font-size:12pt;">Shareholder and Company each are a party to that certain Stockholders&#8217; Agreement, dated as of December 31, 2014 by and among the Company, Shareholder, the Subsidiary and certain other Management Investors (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Stockholders&#8217; Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;);</font></div><div style="line-height:120%;padding-left:0px;padding-bottom:16px;text-align:justify;text-indent:48px;"><font style="padding-bottom:16px;text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">B.</font><font style="font-family:inherit;font-size:12pt;">The parties hereto have determined that with respect to 46,751 shares of Subsidiary Common Stock (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exchanged Subsidiary Shares</font><font style="font-family:inherit;font-size:12pt;">&#8221;), the parties desire to effect an exchange of the Exchanged Subsidiary Shares for common stock of the Company, par value $0.01 per share (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Company Common Stock</font><font style="font-family:inherit;font-size:12pt;">&#8221;) on the terms and subject to the conditions of this Agreement (such transaction, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exchange</font><font style="font-family:inherit;font-size:12pt;">&#8221;);</font></div><div style="line-height:120%;padding-left:0px;padding-bottom:16px;text-align:justify;text-indent:48px;"><font style="padding-bottom:16px;text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">C.</font><font style="font-family:inherit;font-size:12pt;">As of the date hereof, the Company and Shareholder agree that the Fair Market Value of the Exchanged Subsidiary Shares, as determined pursuant to the Stockholders&#8217; Agreement, is $45,312,471.73 (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exchanged Subsidiary Shares Value</font><font style="font-family:inherit;font-size:12pt;">&#8221;).</font></div><div style="line-height:120%;padding-left:0px;padding-bottom:16px;text-align:justify;text-indent:48px;"><font style="padding-bottom:16px;text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">D.</font><font style="font-family:inherit;font-size:12pt;">The Company desires to deliver a number of shares of Company Common Stock as determined under this Agreement (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exchanged Company Shares</font><font style="font-family:inherit;font-size:12pt;">&#8221;) to Shareholder in exchange for the Exchanged Subsidiary Shares, on the terms and subject to the conditions of this Agreement; and</font></div><div style="line-height:120%;padding-left:0px;padding-bottom:16px;text-align:justify;text-indent:48px;"><font style="padding-bottom:16px;text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">E.</font><font style="font-family:inherit;font-size:12pt;">It is the intention of the parties hereto that the Exchange shall be a transaction satisfying the requirements of section 368(a) of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Code</font><font style="font-family:inherit;font-size:12pt;">&#8221;).</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">AGREEMENT</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as set forth below.  All capitalized terms used but not herein defined shall have the meaning set forth in the Stockholders&#8217; Agreement.</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-left:0px;padding-bottom:16px;text-align:justify;text-indent:48px;"><font style="padding-bottom:16px;text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">1.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Matters Related to the Stockholders&#8217; Agreement</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">a.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Pursuant to subparagraph (vi) of the definition of &#8220;Permitted Transferee&#8221; in the Stockholders&#8217; Agreement, the Company hereby approves the Exchange and the transfer of the Exchanged Subsidiary Shares to the Company, and the Subsidiary hereby acknowledges and agrees that the Company is a &#8220;Permitted Transferee&#8221; as defined in the Stockholders&#8217; Agreement.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">b.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Subsidiary hereby waives any requirement that the Shareholder deliver to the Subsidiary the opinion described in Section 3.02 of the Stockholders&#8217; Agreement in connection with the Exchange.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">c.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Pursuant to Section 3.01 of the Stockholders&#8217; Agreement, the Company agrees to take the Exchanged Subsidiary Shares subject to, and to comply with, all of the provisions of the Stockholders&#8217; Agreement applicable thereto, and shall cause a copy of this Agreement to be filed with the Secretary of the Subsidiary.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Mechanics of Exchange</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">a.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">No earlier than February 11, 2020 and no later than the end of the day on March 12, 2020 (such period, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exchange Notice Period</font><font style="font-family:inherit;font-size:12pt;">&#8221;), Shareholder may deliver a notice (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exchange Notice</font><font style="font-family:inherit;font-size:12pt;">&#8221;) in writing to the Company of Shareholder&#8217;s intention to exchange all, but not less than all, of the Exchanged Subsidiary Shares for the number of Exchanged Company Shares determined pursuant to this Section 2.  If no Exchange Notice is delivered by the Shareholder during the Exchange Notice Period, this Agreement shall terminate and be of no further force or effect with respect to the Exchanged Subsidiary Shares.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">b.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">No later than five (5) business days following receipt of the Exchange Notice, the Company shall deliver to Shareholder a calculation setting forth the number of Exchanged Company Shares to be delivered in the Exchange.  The number of shares of Exchanged Company Shares to be delivered in the Exchange shall be determined by dividing the Exchanged Subsidiary Shares Value by an amount per share (rounded to two decimal places) equal to </font><font style="font-family:inherit;font-size:11.5pt;">the last reported sales price of a share of the Common Stock on the composite tape of the </font><font style="font-family:inherit;font-size:12pt;">New York Stock Exchange (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">NYSE</font><font style="font-family:inherit;font-size:12pt;">&#8221;) </font><font style="font-family:inherit;font-size:11.5pt;">on the date on which the Exchange Notice was delivered</font><font style="font-family:inherit;font-size:12pt;">&#32;(the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exchanged Company Shares Value</font><font style="font-family:inherit;font-size:12pt;">&#8221;). If the Exchange Notice is delivered after 5 p.m. central time or on a day on which the NYSE was not open for trading, the Exchanged Company Shares Value will be determined using the </font><font style="font-family:inherit;font-size:11.5pt;">last reported sales price </font><font style="font-family:inherit;font-size:12pt;">for the Company Common Stock on the next trading day following the date on which the Exchange Notice was delivered.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">c.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">No later than five (5) days following the delivery by the Company of its determination of the Exchanged Company Shares Value, provided that any conditions precedent and closing deliveries have been satisfied or provided, as applicable, Shareholder shall transfer to the Company all of Shareholder&#8217;s right, title and interest in and to the Exchanged Subsidiary Shares and in consideration of the assignment by Shareholder of the </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Exchanged Subsidiary Shares, the Company shall deliver to Shareholder the Exchanged Company Shares, rounded down to the nearest whole number of shares, and cash in an amount equal to the Exchanged Company Share Value multiplied by the number of fractional shares of Company Common Stock that otherwise would have been issued in the Exchange (the consummation of such transfer and delivery, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Closing</font><font style="font-family:inherit;font-size:12pt;">&#8221;). The Company and the Shareholder agree that payment of cash in lieu of fractional shares of Company Common Stock is solely for the purpose of avoiding the expense and inconvenience to the Company of issuing fractional shares and does not represent separately bargained-for consideration.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Representations and Warranties of the Company</font><font style="font-family:inherit;font-size:12pt;">.  The Company hereby represents and warrants to Shareholder as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">a.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The execution and delivery by the Company of this Agreement, and the performance of its obligations hereunder, have been duly and validly authorized by all necessary actions of the Company.  This Agreement has been duly and validly executed and delivered by the Company and constitutes the legal, valid and binding obligations of the Company, enforceable against the Company, in accordance with its terms, except to the extent such enforceability (i) may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to creditors&#8217; rights generally and (ii) is subject to general principles of equity.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">b.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The consummation of the transactions contemplated by this Agreement and the execution, delivery and performance of the terms and provisions of this Agreement by the Company will not (i) contravene, result in any breach of, or constitute a default under, any material agreement or instrument to which the Company is a party, (ii) conflict with or result in a breach of any of the terms, conditions or provisions of any order of any court, arbitrator or governmental authority applicable to the Company, or (iii) violate any provision of any statute or other rule or regulation of any governmental authority applicable to the Company.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">c.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Exchanged Company Shares sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully paid and nonassessable.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Representations and Warranties of Shareholder</font><font style="font-family:inherit;font-size:12pt;">.  Shareholder represents and warrants to the Company as follows:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">a.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Shareholder is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization with the requisite power and authority to enter into and to consummate the transactions contemplated by this Agreement, to effect the Exchange, and otherwise to carry out its obligations hereunder and thereunder.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">b.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The execution and delivery by Shareholder of this Agreement, and the performance of its obligations hereunder, have been duly and validly authorized by all necessary actions of Shareholder.  This Agreement has been duly and validly executed and delivered by Shareholder and constitutes the legal, valid and binding obligations of </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Shareholder, enforceable against Shareholder, in accordance with its terms, except to the extent such enforceability (i) may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to creditors&#8217; rights generally and (ii) is subject to general principles of equity.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">c.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The consummation of the transactions contemplated by this Agreement and the execution, delivery and performance of the terms and provisions of this Agreement by Shareholder will not (i) contravene, result in any breach of, or constitute a default under, any material agreement or instrument to which Shareholder is a party, (ii) conflict with or result in a breach of any of the terms, conditions or provisions of any order of any court, arbitrator or governmental authority applicable to Shareholder, or (iii) violate any provision of any statute or other rule or regulation of any governmental authority applicable to Shareholder.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">d.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Shareholder is the sole and exclusive legal and beneficial owner of the Exchanged Subsidiary Shares, free and clear of all prior claims and any lien, mortgage, security interest, pledge, restriction on transferability, and there are no (i) voting trusts, stockholder or other agreements, proxies or other understandings in effect (except for the Stockholders&#8217; Agreement) with respect to the voting or transfer of any of the Exchanged Subsidiary Shares or (ii) judgments, orders, injunctions, decrees, stipulations or awards (whether rendered by a court, administrative agency, arbitral body or governmental authority) against Shareholder with respect to any of the Exchanged Subsidiary Shares.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">e.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Shareholder is acquiring all of the Exchanged Company Shares for Shareholder&#8217;s own account, for investment purposes, and not with a view to or for sale in connection with any distribution of the Exchanged Company Shares.  Shareholder specifically represents that the entire legal and beneficial interest in the Exchanged Company Shares is being acquired for, and will be held for, Shareholder&#8217;s account only and not for the account of, or otherwise on behalf of, any other person.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">f.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Shareholder has had a full opportunity to ask questions through its representatives and to receive answers concerning the terms and conditions of the transactions contemplated by this Agreement and has had full access to the Company&#8217;s officers and such other information concerning the Company as he has requested.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">g.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Shareholder is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Act</font><font style="font-family:inherit;font-size:12pt;">&#8221;). </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">h.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">By reason of Shareholder&#8217;s business or financial experience, Shareholder has the capacity to protect Shareholder&#8217;s own interests in connection with the transactions contemplated by this Agreement, and Shareholder can bear the risk of losing Shareholder&#8217;s entire investment in the Company.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">i.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Shareholder is a &#8220;United States person&#8221; within the meaning of Section 7701(a)(30) of the Code and the Treasury Regulations thereunder.</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">j.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Shareholder has relied only upon its own tax advisor and legal counsel with respect to the federal, state, local, foreign and other tax consequences arising from such Shareholder&#8217;s acquisition, ownership, and potential future disposition of the Exchanged Company Shares in the Exchange, and not on the Company or the Subsidiary, or either of their respective advisors.  Shareholder acknowledges that neither the Company, the Subsidiary, nor their respective advisors has made any representations regarding the federal, state, local, foreign or other tax consequences of consummating the transactions contemplated by this Agreement.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Legends</font><font style="font-family:inherit;font-size:12pt;">.  Shareholder acknowledges that (i) the offer and sale of the Exchanged Company Shares in the Exchange have not been registered under the Act, or registered or qualified under the securities laws of any state, and instead have been offered and are being sold pursuant to one or more exemptions from registration or qualification, and (ii) the Exchanged Company Shares are &#8220;restricted securities&#8221; within the meaning of Rule 144 under the Act,  and Shareholder may not sell or otherwise transfer the Exchanged Company Shares unless they are subsequently registered under the Act and registered or qualified under applicable state securities laws, or unless an exemption is available which permits the sale or other transfer without such registration and qualification.  Shareholder acknowledges that the Company has no obligation to register the Exchanged Company Shares or to ensure that any sale or other transfer of the Exchanged Company Shares by Shareholder complies with the requirements of any exemption from such registration or qualification.  Shareholder understands and agrees that all certificates, if any, evidencing the Exchanged Company Shares to be issued to Shareholder shall bear substantially the following legend:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS.  THEY MAY NOT BE SOLD OR OTHERWISE TRANSFERRED OR DISPOSED OF UNLESS THEY HAVE BEEN REGISTERED UNDER SUCH ACT AND ALL SUCH APPLICABLE LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">6.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Transaction Upon Execution</font><font style="font-family:inherit;font-size:12pt;">. &#160;&#160;&#160;&#160;The following deliveries and transactions shall take place at the Closing:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">a.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Company shall deliver or cause to be delivered to Shareholder:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">i.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the Exchanged Company Shares, recorded in book-entry form or certificated form, as determined by the Company in its sole discretion, in the name of Shareholder with the Company&#8217;s transfer agent, Computershare, Inc.; </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ii.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">cash (by check, money order or wire transfer) in lieu of the issuance of any Fractional Shares, in such amount as provided for in Section 2(c) of this Agreement; and</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">iii.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">such further instruments and documents as may be necessary or appropriate to consummate the transactions contemplated herein, all duly executed by the Company.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">b.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Shareholder shall deliver to the Company:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">i.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">stock certificates of Subsidiary evidencing the Exchanged Subsidiary Shares, together with appropriate stock powers executed in blank;</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt"> </sup>&#160;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ii.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">a certificate substantially in the form set forth in, and satisfying the requirements of, Treasury regulation section 1.1445-2(b)(2), in form and substance reasonably satisfactory to the Company, and an executed IRS Form W-9 or applicable successor form; </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">iii.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">a copy of the notice provided to the Subsidiary as required under Section 3.01 of the Stockholders&#8217; Agreement; and</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">iv.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">such further instruments and documents as may be reasonably necessary or appropriate to consummate the transactions contemplated herein, all duly executed by Shareholder.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">General Provisions</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">a.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Successors and Assigns</font><font style="font-family:inherit;font-size:12pt;">.  This Agreement will be binding on the parties and their respective legal representatives, successors and permitted assigns.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">b.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">No Third Party Beneficiaries</font><font style="font-family:inherit;font-size:12pt;">.  Except as may be expressly provided in this Agreement, there shall be no third party beneficiaries.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">c.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Governing Law; Jurisdiction</font><font style="font-family:inherit;font-size:12pt;">.  This Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware, without regard to conflict of law principles that would result in the application of any law other than the law of the State of Delaware.  The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state and federal courts located in the State of Delaware for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Covered Matters</font><font style="font-family:inherit;font-size:12pt;">&#8221;), (ii) agree not to commence any suit, action or other proceeding arising out of or based upon any Covered Matters except in the state or federal courts located in the State of Delaware, and (iii) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that a party is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter of any Covered Matter may not be enforced in or by such court.</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">d.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Further Assurances</font><font style="font-family:inherit;font-size:12pt;">.  The Company and Shareholder shall, at any time and from time to time following the date hereof promptly execute and deliver, or cause to be executed and delivered all such further instruments and take all such further actions as may be reasonably necessary or appropriate to confirm or carry out the purposes and intent of this Agreement.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">e.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Entire Agreement</font><font style="font-family:inherit;font-size:12pt;">.  This Agreement constitutes the full and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties is expressly canceled.  </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">f.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Counterparts</font><font style="font-family:inherit;font-size:12pt;">.  This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute a single agreement.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">g.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Amendment</font><font style="font-family:inherit;font-size:12pt;">.  This Agreement may be amended or modified only by a written instrument executed by all of the parties to this Agreement.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">h.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Counterparts; Delivery</font><font style="font-family:inherit;font-size:12pt;">.  This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.  Counterparts may be delivered via electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">e.g.</font><font style="font-family:inherit;font-size:12pt;">, www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">i.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Withholding</font><font style="font-family:inherit;font-size:12pt;">.  The Company shall be entitled to deduct and withhold from any transfers to be made under this Agreement any amounts required to be deducted or withheld under applicable federal, state, local or foreign law; provided, that Company does not expect to be required to withhold any amounts from any transfers made under this Agreement provided that Shareholder complies with Section 6(b)(ii) hereof.  Any amount so deducted and withheld, when paid over to the appropriate governmental authority, shall be treated as having been paid to the person in respect of which such deduction or withholding was made for all purposes of this Agreement.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">j.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Notices</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">. </font><font style="font-family:inherit;font-size:12pt;">All notices, requests, demands, claims and other communications required or permitted hereunder will be in writing and will be sent by personal delivery, nationally recognized overnight courier or facsimile or, provided that one of the foregoing methods of delivery is also used, by e-mail (as a PDF). Any notice, request, demand, claim, or other communication required or permitted hereunder will be   deemed duly given, as applicable, (1) upon personal delivery, (2) one (1) Business Day following the date sent when sent by courier delivery or (3) upon confirmation of receipt when sent by facsimile or e-mail (as a PDF), addressed as follows:</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If to the Company, to:</font></div><div style="padding-bottom:16px;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Encompass Health Corporation <br>9001 Liberty Parkway <br>Birmingham, Alabama 35242 <br>Telephone number: (205) 967-7116 <br>Facsimile number: (205) 262-3948 <br>Attention: General Counsel</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If to Shareholder, to:</font><font style="font-family:inherit;font-size:10pt;">&#160;<br></font><font style="font-family:inherit;font-size:12pt;">&#160;<br>HCHB Consulting, Inc.</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">c/o April Anthony</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3616 Euclid Avenue</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Dallas, Texas 75205</font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#32;&#32;&#32;&#32;&#32;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#32;[</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">Signature Page Follows</font><font style="font-family:inherit;font-size:12pt;">]</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the day and year first above written.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">COMPANY:</font></div><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ENCOMPASS HEALTH CORPORATION</font></div><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">&#160;&#160;&#160;&#160;/s/ Patrick Darby&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Name: Patrick Darby</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:336px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:288px;"><font style="font-family:inherit;font-size:12pt;">Title:</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Executive Vice President, General Counsel and Secretary</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SHAREHOLDER:</font></div><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">HCHB CONSULTING, INC.</font></div><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By: </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">/s/ April Anthony&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Name: April Anthony <br>Title:  President</font><font style="font-family:inherit;font-size:10pt;">&#32;<br> <br></font></div><div style="line-height:120%;text-align:left;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SUBSIDIARY </font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">(Solely for purposes of Section 1 hereof):</font></div><div style="line-height:120%;text-align:left;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ENCOMPASS HEALTH HOME HEALTH HOLDINGS, INC.</font></div><div style="line-height:120%;text-align:left;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">&#160;&#160;&#160;&#160;/s/ Patrick Darby&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Name: Patrick Darby</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:336px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:288px;"><font style="font-family:inherit;font-size:12pt;">Title:</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Vice President and Secretary</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ehc-20200219.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.encompasshealth.com/20200219" xmlns:ehc="http://www.encompasshealth.com/20200219" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20200219_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20200219_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20200219_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20200219_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="DocumentAndEntityInformationDocumentAndEntityInformation" roleURI="http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation">
        <link:definition>0001000 - Document - Document and Entity Information Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>ehc-20200219_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:href="ehc-20200219.xsd#DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>ehc-20200219_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:href="ehc-20200219.xsd#DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>ehc-20200219_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_CoverAbstract_B7599081BDC4EDF4143712F0BB3A231D_label_en-US" xlink:label="lab_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover page.</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="lab_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_E2D61CA4991F92A4957712F0BB475CB7_terseLabel_en-US" xlink:label="lab_dei_DocumentType_9CA99C0EEE0B50CC9F93796D491D6410" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_E2D61CA4991F92A4957712F0BB475CB7_label_en-US" xlink:label="lab_dei_DocumentType_9CA99C0EEE0B50CC9F93796D491D6410" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_9CA99C0EEE0B50CC9F93796D491D6410" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_9CA99C0EEE0B50CC9F93796D491D6410" xlink:to="lab_dei_DocumentType_9CA99C0EEE0B50CC9F93796D491D6410" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_ABC14673FCBEA5F05BCF131210038A0B_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_3F7E678FEFAE5A77BDA9578EED765950" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_ABC14673FCBEA5F05BCF131210038A0B_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_3F7E678FEFAE5A77BDA9578EED765950" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_3F7E678FEFAE5A77BDA9578EED765950" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_3F7E678FEFAE5A77BDA9578EED765950" xlink:to="lab_dei_DocumentPeriodEndDate_3F7E678FEFAE5A77BDA9578EED765950" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_5F85E34E2E0D7BA2E08713121019DC04_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_553375AB5E855EF2896A0E954742AC89" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_5F85E34E2E0D7BA2E08713121019DC04_label_en-US" xlink:label="lab_dei_EntityRegistrantName_553375AB5E855EF2896A0E954742AC89" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_553375AB5E855EF2896A0E954742AC89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_553375AB5E855EF2896A0E954742AC89" xlink:to="lab_dei_EntityRegistrantName_553375AB5E855EF2896A0E954742AC89" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1DDF7343A1EA4EB77CE813121029DEA2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_E99A2E34946256A8A90911DFE90415D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1DDF7343A1EA4EB77CE813121029DEA2_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_E99A2E34946256A8A90911DFE90415D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_E99A2E34946256A8A90911DFE90415D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_E99A2E34946256A8A90911DFE90415D1" xlink:to="lab_dei_EntityIncorporationStateCountryCode_E99A2E34946256A8A90911DFE90415D1" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_5A2031BC605B072F17A912FE36BA31CD_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_D049A602166E545DA0A43333CE95F75E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_5A2031BC605B072F17A912FE36BA31CD_label_en-US" xlink:label="lab_dei_EntityFileNumber_D049A602166E545DA0A43333CE95F75E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_D049A602166E545DA0A43333CE95F75E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_D049A602166E545DA0A43333CE95F75E" xlink:to="lab_dei_EntityFileNumber_D049A602166E545DA0A43333CE95F75E" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_58481090530250CF0A6613028813A217_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_7F980A5F7CEF52F9A5F40B266093E3AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_58481090530250CF0A6613028813A217_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_7F980A5F7CEF52F9A5F40B266093E3AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_7F980A5F7CEF52F9A5F40B266093E3AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_7F980A5F7CEF52F9A5F40B266093E3AC" xlink:to="lab_dei_EntityTaxIdentificationNumber_7F980A5F7CEF52F9A5F40B266093E3AC" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_FD79E3B1C70DFCFC628E131210398BF5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_678123F760CB531687C27C45BEB1D5F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_FD79E3B1C70DFCFC628E131210398BF5_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_678123F760CB531687C27C45BEB1D5F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_678123F760CB531687C27C45BEB1D5F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_678123F760CB531687C27C45BEB1D5F3" xlink:to="lab_dei_EntityAddressAddressLine1_678123F760CB531687C27C45BEB1D5F3" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_AE20A26E3F9DBFDA1E6113121049BCD0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_FF9533C1621D579C9C7508168E89F703" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_AE20A26E3F9DBFDA1E6113121049BCD0_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_FF9533C1621D579C9C7508168E89F703" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_FF9533C1621D579C9C7508168E89F703" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_FF9533C1621D579C9C7508168E89F703" xlink:to="lab_dei_EntityAddressCityOrTown_FF9533C1621D579C9C7508168E89F703" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_D22E2F944F896F8333E81312105A4438_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_557DF678EB70584FA76E0D671D438943" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_D22E2F944F896F8333E81312105A4438_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_557DF678EB70584FA76E0D671D438943" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_557DF678EB70584FA76E0D671D438943" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_557DF678EB70584FA76E0D671D438943" xlink:to="lab_dei_EntityAddressStateOrProvince_557DF678EB70584FA76E0D671D438943" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_D4B388879CD0F8F02C7E131210697167_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_8CA61CF044225699872E258FC62A9E17" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_D4B388879CD0F8F02C7E131210697167_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_8CA61CF044225699872E258FC62A9E17" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_8CA61CF044225699872E258FC62A9E17" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_8CA61CF044225699872E258FC62A9E17" xlink:to="lab_dei_EntityAddressPostalZipCode_8CA61CF044225699872E258FC62A9E17" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_D2FB604197A75DF70EE01312108003E4_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_2BBCC6C381A35FF89A42BBD90EE8FE33" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_D2FB604197A75DF70EE01312108003E4_label_en-US" xlink:label="lab_dei_CityAreaCode_2BBCC6C381A35FF89A42BBD90EE8FE33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_2BBCC6C381A35FF89A42BBD90EE8FE33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_2BBCC6C381A35FF89A42BBD90EE8FE33" xlink:to="lab_dei_CityAreaCode_2BBCC6C381A35FF89A42BBD90EE8FE33" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_32FDB07A738E3412B772131210972553_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_84A9F8FF02B154F696A671F4775DA0C4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_32FDB07A738E3412B772131210972553_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_84A9F8FF02B154F696A671F4775DA0C4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_84A9F8FF02B154F696A671F4775DA0C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_84A9F8FF02B154F696A671F4775DA0C4" xlink:to="lab_dei_LocalPhoneNumber_84A9F8FF02B154F696A671F4775DA0C4" xlink:type="arc" />
    <link:label id="lab_dei_WrittenCommunications_BA656314572CECA63D53130904B55EE5_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications_E129BBC15F9958BF820E4B72F6884891" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_BA656314572CECA63D53130904B55EE5_label_en-US" xlink:label="lab_dei_WrittenCommunications_E129BBC15F9958BF820E4B72F6884891" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_E129BBC15F9958BF820E4B72F6884891" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications_E129BBC15F9958BF820E4B72F6884891" xlink:to="lab_dei_WrittenCommunications_E129BBC15F9958BF820E4B72F6884891" xlink:type="arc" />
    <link:label id="lab_dei_SolicitingMaterial_640C96751618317D45D71309B670F526_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial_A6A5C15B3A8C59FC81FE31300D886C69" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_640C96751618317D45D71309B670F526_label_en-US" xlink:label="lab_dei_SolicitingMaterial_A6A5C15B3A8C59FC81FE31300D886C69" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_A6A5C15B3A8C59FC81FE31300D886C69" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial_A6A5C15B3A8C59FC81FE31300D886C69" xlink:to="lab_dei_SolicitingMaterial_A6A5C15B3A8C59FC81FE31300D886C69" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_15C3A4A2179DDECF0603130A74CDAAF9_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_FD51C37ACFCD56F080AD95EF5067CECC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_15C3A4A2179DDECF0603130A74CDAAF9_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_FD51C37ACFCD56F080AD95EF5067CECC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_FD51C37ACFCD56F080AD95EF5067CECC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer_FD51C37ACFCD56F080AD95EF5067CECC" xlink:to="lab_dei_PreCommencementIssuerTenderOffer_FD51C37ACFCD56F080AD95EF5067CECC" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementTenderOffer_139351952016DF450DFB130B2B537E0B_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_E1461F64A1BF5A6AA17AB228A99B976E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_139351952016DF450DFB130B2B537E0B_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_E1461F64A1BF5A6AA17AB228A99B976E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_E1461F64A1BF5A6AA17AB228A99B976E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer_E1461F64A1BF5A6AA17AB228A99B976E" xlink:to="lab_dei_PreCommencementTenderOffer_E1461F64A1BF5A6AA17AB228A99B976E" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_96D210AEC33BD1FC9E8D1314665D7C81_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_489A8771FBD7561BA0A20E0282870019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_96D210AEC33BD1FC9E8D1314665D7C81_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_489A8771FBD7561BA0A20E0282870019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_489A8771FBD7561BA0A20E0282870019" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_489A8771FBD7561BA0A20E0282870019" xlink:to="lab_dei_EntityEmergingGrowthCompany_489A8771FBD7561BA0A20E0282870019" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_3CEE6C7BA3EAC9C89F51130ED95658C4_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_0DAA76C913B5573095EB98265DBD36B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_3CEE6C7BA3EAC9C89F51130ED95658C4_label_en-US" xlink:label="lab_dei_Security12bTitle_0DAA76C913B5573095EB98265DBD36B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_0DAA76C913B5573095EB98265DBD36B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_0DAA76C913B5573095EB98265DBD36B5" xlink:to="lab_dei_Security12bTitle_0DAA76C913B5573095EB98265DBD36B5" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_814C86FD7AE08DC4E28313103AE02F1B_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_2021C046D1F95625A7AAD8B8693E9FE1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_814C86FD7AE08DC4E28313103AE02F1B_label_en-US" xlink:label="lab_dei_TradingSymbol_2021C046D1F95625A7AAD8B8693E9FE1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_2021C046D1F95625A7AAD8B8693E9FE1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_2021C046D1F95625A7AAD8B8693E9FE1" xlink:to="lab_dei_TradingSymbol_2021C046D1F95625A7AAD8B8693E9FE1" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_BACA992C556D504DDE9213115B1F4A72_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_84D947EA0C1D5FE8BE19B87806A1C320" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_BACA992C556D504DDE9213115B1F4A72_label_en-US" xlink:label="lab_dei_SecurityExchangeName_84D947EA0C1D5FE8BE19B87806A1C320" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_84D947EA0C1D5FE8BE19B87806A1C320" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_84D947EA0C1D5FE8BE19B87806A1C320" xlink:to="lab_dei_SecurityExchangeName_84D947EA0C1D5FE8BE19B87806A1C320" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_60FFF57D0A2EDF7384A213160F9D213E_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_9EDDCFEDCFE057D293AB8A7F8282088E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_60FFF57D0A2EDF7384A213160F9D213E_label_en-US" xlink:label="lab_dei_AmendmentFlag_9EDDCFEDCFE057D293AB8A7F8282088E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_9EDDCFEDCFE057D293AB8A7F8282088E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_9EDDCFEDCFE057D293AB8A7F8282088E" xlink:to="lab_dei_AmendmentFlag_9EDDCFEDCFE057D293AB8A7F8282088E" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_D3978EFB0A70693525C01316D1CF285A_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_A62D90357F4F5585BB4DC61E7313745D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_D3978EFB0A70693525C01316D1CF285A_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_A62D90357F4F5585BB4DC61E7313745D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_A62D90357F4F5585BB4DC61E7313745D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_A62D90357F4F5585BB4DC61E7313745D" xlink:to="lab_dei_EntityCentralIndexKey_A62D90357F4F5585BB4DC61E7313745D" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>ehc-20200219_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:href="ehc-20200219.xsd#DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_D6CF5428DFA952328504FFDBFE4B7878" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_DocumentType_D6CF5428DFA952328504FFDBFE4B7878" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_3F7E678FEFAE5A77BDA9578EED765950" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_DocumentPeriodEndDate_3F7E678FEFAE5A77BDA9578EED765950" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_553375AB5E855EF2896A0E954742AC89" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_EntityRegistrantName_553375AB5E855EF2896A0E954742AC89" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_E99A2E34946256A8A90911DFE90415D1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_E99A2E34946256A8A90911DFE90415D1" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_D049A602166E545DA0A43333CE95F75E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_EntityFileNumber_D049A602166E545DA0A43333CE95F75E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_7F980A5F7CEF52F9A5F40B266093E3AC" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_EntityTaxIdentificationNumber_7F980A5F7CEF52F9A5F40B266093E3AC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_678123F760CB531687C27C45BEB1D5F3" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_EntityAddressAddressLine1_678123F760CB531687C27C45BEB1D5F3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_FF9533C1621D579C9C7508168E89F703" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_EntityAddressCityOrTown_FF9533C1621D579C9C7508168E89F703" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_557DF678EB70584FA76E0D671D438943" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_EntityAddressStateOrProvince_557DF678EB70584FA76E0D671D438943" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_8CA61CF044225699872E258FC62A9E17" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_EntityAddressPostalZipCode_8CA61CF044225699872E258FC62A9E17" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_2BBCC6C381A35FF89A42BBD90EE8FE33" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_CityAreaCode_2BBCC6C381A35FF89A42BBD90EE8FE33" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_84A9F8FF02B154F696A671F4775DA0C4" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_LocalPhoneNumber_84A9F8FF02B154F696A671F4775DA0C4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_E129BBC15F9958BF820E4B72F6884891" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_WrittenCommunications_E129BBC15F9958BF820E4B72F6884891" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_A6A5C15B3A8C59FC81FE31300D886C69" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_SolicitingMaterial_A6A5C15B3A8C59FC81FE31300D886C69" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_FD51C37ACFCD56F080AD95EF5067CECC" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_FD51C37ACFCD56F080AD95EF5067CECC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_E1461F64A1BF5A6AA17AB228A99B976E" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_PreCommencementTenderOffer_E1461F64A1BF5A6AA17AB228A99B976E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_489A8771FBD7561BA0A20E0282870019" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_EntityEmergingGrowthCompany_489A8771FBD7561BA0A20E0282870019" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_0DAA76C913B5573095EB98265DBD36B5" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_Security12bTitle_0DAA76C913B5573095EB98265DBD36B5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_2021C046D1F95625A7AAD8B8693E9FE1" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_TradingSymbol_2021C046D1F95625A7AAD8B8693E9FE1" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_84D947EA0C1D5FE8BE19B87806A1C320" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_SecurityExchangeName_84D947EA0C1D5FE8BE19B87806A1C320" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_9EDDCFEDCFE057D293AB8A7F8282088E" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_AmendmentFlag_9EDDCFEDCFE057D293AB8A7F8282088E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_A62D90357F4F5585BB4DC61E7313745D" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7EB5A5D80C9B55EDBB55ACB8239DFEE6" xlink:to="loc_dei_EntityCentralIndexKey_A62D90357F4F5585BB4DC61E7313745D" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>9
<FILENAME>0000785161-20-000009-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000785161-20-000009-xbrl.zip
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M]=>VU;R@LOEF)=GF/CKZ!U!+ P04    " ";A%50'L_].4L!   & P  %
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M5<O.0_HADC/)CS*P61>_XU[*_^B]- :M Y5#'EJ;T+O?..V] 5!+ P04
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M?M92TL1"XFPZS/*[+)^OFUX4@4<FNY\6^7>3C=(^M-9S3+""3A&G.3=.+$H
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MO.+, <LXM*$'25X;*4\+D"N!-;D2[64D7+JTL1EAJCO8.F9>F%*%-75]?&/
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MK=+3<I;6F[&7=7W]?CJ]O;T]6E_Z_*CTBRE!*)C^:+47T7R;/,(FS:D))I,
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M Y,J,YT>PQ)@>;[T2-6*M5F@I] JC<=![0&VXX6C28FG#M8!MD)? O?*$ Q
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M,7U<!.1SHS .1S:EXOP#*$P](+@> 8T<<@@V2FVIH6-3C%+7'* @\3X46^G
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MP]+6F.L<6)U*,!NM>1=@M8GQDIZ!0TV/BN$55/^%&5IG6%!-\7"8!$(G6@"
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M^;JLU@!H7%&]+*E-H!JO_*$ 6 G="IS'-=8$*77-^?_].\HAFXUZW;ZI]P9
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M_/Z)TT?O+_&R#G&HT ?)%=$L>S++[:6!+J5\U_EB-8=?WF1/EZ)\$.!$]1<
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M2P$"% ,4    " ";A%50'L_].4L!   & P  %               @ &4 P
M96AC+3(P,C P,C$Y7V-A;"YX;6Q02P$"% ,4    " ";A%50'317G:X!  !8
M!@  %               @ $1!0  96AC+3(P,C P,C$Y7V1E9BYX;6Q02P$"
M% ,4    " ";A%50K4/LG+(+   >9@  %               @ 'Q!@  96AC
M+3(P,C P,C$Y7VQA8BYX;6Q02P$"% ,4    " ";A%50V\&43*8&  "B-0
M%               @ '5$@  96AC+3(P,C P,C$Y7W!R92YX;6Q02P$"% ,4
M    " ";A%505'$:]/L>  !.Q0  &@              @ &M&0  97@Q,#%E
M>&-H86YG96%G<F5E;65N="YH=&U02P$"% ,4    " ";A%50U/L9^],C  !.
M\@  &@              @ '@.   9F5B<G5A<GDR,#(P97AE8W5T:79E8RYH
8=&U02P4&      < !P#6 0  ZUP

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>february2020executivec_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ehc-20200219.xsd" xlink:type="simple"/>
    <context id="D2020Q1Feb19-2020throughFeb19-2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000785161</identifier>
        </entity>
        <period>
            <startDate>2020-02-19</startDate>
            <endDate>2020-02-19</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="Fact-E978957CA507524688EE9CFFAB6C4617-wk-Fact-E978957CA507524688EE9CFFAB6C4617">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="Fact-8D26389E1F085441B09086D7D4D8C24A-wk-Fact-8D26389E1F085441B09086D7D4D8C24A">0000785161</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e94-wk-Fact-B41F40D49B2354B1A603B0011EE7B261">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e108-wk-Fact-6F2C87EC974A54128564087E9E6E3560">2020-02-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e113-wk-Fact-19C8521BB0FE5799B79FF73CDDD070E7">Encompass Health Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e122-wk-Fact-0F022CDC6D2C52F4B012EABC06888552">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e144-wk-Fact-7106E2FD3B655B3782D962D5A6BBF533">001-10315</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e149-wk-Fact-6C326105A17359F6860CF30D36CB7276">63-0860407</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e174-wk-Fact-F61F99B4129F5AA6B15D9A0E29CF591F">9001 Liberty Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e179-wk-Fact-A400BD59D9CB5157A97D470F29FE155C">Birmingham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e184-wk-Fact-B97B1374D21952BD8AAD0BC53E08136C">AL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e189-wk-Fact-5EDDB24E37225A5689A518DD741A13F3">35242</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e200-wk-Fact-132998FB6FFA523AA8F04C3A75C27AF8">205</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e205-wk-Fact-527D2FBC0BE35D8D816A994D7E4159F1">967-7116</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e229-wk-Fact-2AE0B89C9F0358E598A780DEFE4DC7A4">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e251-wk-Fact-3588505CE5B558598119DDA7728E1385">false</dei:SolicitingMaterial>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e273-wk-Fact-D1C4994AFF865DB08E8C86F9BC1ED1C3">false</dei:PreCommencementIssuerTenderOffer>
    <dei:PreCommencementTenderOffer
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e295-wk-Fact-CD02BE6F69CA54E28794E30F7586A7BA">false</dei:PreCommencementTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e307-wk-Fact-C5D2ADD2BDD1544FA9C4BF03A64B1316">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e348-wk-Fact-D19C5C5E149A5E24887951296B58E8F4">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e353-wk-Fact-07B9233F48C956ECBC3FFC26E859C806">EHC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="D2020Q1Feb19-2020throughFeb19-2020"
      id="d43646476e358-wk-Fact-8316355A38E152E09EB39B82DCD2B362">NYSE</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6629691152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 19, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover page.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 19,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Encompass Health Corporation<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-10315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">63-0860407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9001 Liberty Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Birmingham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">AL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">35242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">967-7116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EHC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000785161<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MX7<5=M[8O?W'QA?!KH5?_Z+[ E!+ P04    " ";A%50F5R<(Q &  "<)P
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MVF)"\JWA ;US,GK:G>NP%7Y8 OHY]/\!4$L#!!0    ( )N$55"ZH3F*UP$
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M 0  5P0  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULM51-3\,P#/TK4Z]HS>#
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M_\GR"U!+ 0(4 Q0    ( )N$55 ?(\\#P    !,"   +              "
M 0    !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( )N$55 GZ(<.@@   +$    0
M              "  >D   !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
MFX154 ?QH&CN    *P(  !$              ( !F0$  &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ FX154)E<G",0!@  G"<  !,
M ( !M@(  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " ";A%50)UC'
M[)T"  "8"P  &               @ 'W"   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ FX154%%I/)Y9 @  (@8  !0
M ( !R@L  'AL+W-H87)E9%-T<FEN9W,N>&UL4$L! A0#%     @ FX154+JA
M.8K7 0  ,@8   T              ( !50X  'AL+W-T>6QE<RYX;6Q02P$"
M% ,4    " ";A%50%FTC?T,!   \ @  #P              @ %7$   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ FX154/_ )@B]    A0(  !H
M         ( !QQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ FX154 N/V ,A 0  5P0  !,              ( !O!(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      H "@"  @  #A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "february2020executivec.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "ehc-20200219_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ehc-20200219_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "february2020executivec.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ehc-20200219_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ehc-20200219_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "ehc-20200219.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ehc",
   "nsuri": "http://www.encompasshealth.com/20200219",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "february2020executivec.htm",
      "contextRef": "D2020Q1Feb19-2020throughFeb19-2020",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Document and Entity Information Document and Entity Information",
     "role": "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation",
     "shortName": "Document and Entity Information Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "february2020executivec.htm",
      "contextRef": "D2020Q1Feb19-2020throughFeb19-2020",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3.a.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="february2020executivec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Document and Entity Information Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.encompasshealth.com/role/DocumentAndEntityInformationDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="february2020executivec.htm">february2020executivec.htm</File>
    <File>ehc-20200219.xsd</File>
    <File>ehc-20200219_cal.xml</File>
    <File>ehc-20200219_def.xml</File>
    <File>ehc-20200219_lab.xml</File>
    <File>ehc-20200219_pre.xml</File>
    <File>ex101exchangeagreement.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
